Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Archives of Internal Medicine|December 15, 2004
Discontinuation of nonsteroidal anti-inflammatory drug therapy and risk of acute myocardial infarctionLorenz M Fischer, Raymond G Schlienger, Christian M Matter, et al.
Pharmacotherapy|February 24, 2007
Statins and the risk of pneumonia: a population-based, nested case-control studyRaymond G Schlienger, David S Fedson, Susan S Jick, et al.
Critical Care Medicine|January 13, 2005
Hepatotoxicity during rapid intravenous loading with amiodarone: Description of three cases and review of the literatureAlexandra E Rätz Bravo, Juergen Drewe, Raymond G Schlienger, et al.
Drug Safety|March 1, 2005
Prevalence of potentially severe drug-drug interactions in ambulatory patients with dyslipidaemia receiving HMG-CoA reductase inhibitor therapyAlexandra E Rätz Bravo, Lydia Tchambaz, Anita Krähenbühl-Melcher, et al.
The Journal of Allergy and Clinical Immunology|April 14, 2009
Lymphoma among patients with atopic dermatitis and/or treated with topical immunosuppressants in the United KingdomFelix M Arellano, Alejandro Arana, Charles E Wentworth, et al.
Dermatology (Basel, Switzerland)|March 19, 2009
Topical treatments with pimecrolimus, tacrolimus and medium- to high-potency corticosteroids, and risk of lymphomaSebastian Schneeweiss, Mike Doherty, Shao Zhu, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 28, 2017
A Database Cohort Study to Assess the Risk of Angioedema Among Patients with Heart Failure Initiating Angiotensin-Converting Enzyme Inhibitors in the USAThy P Do, Arpamas Seetasith, Rossella Belleli, et al.
Pharmacoepidemiology and Drug Safety|April 3, 2016
The IMI PROTECT project: purpose, organizational structure, and proceduresRobert F Reynolds, Xavier Kurz, Mark C H de Groot, et al.
Pharmacotherapy|May 14, 2003
Validity of the general practice research databaseSusan S Jick, James A Kaye, Catherine Vasilakis-Scaramozza, et al.
Pageof 4